African AIDS Summit import/mfrg accord

1 May 2001

Ministers of African national governments, meeting in Nigeria's capitalof Abuja for the first African Summit on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases, have agreed a declaration urging their countries to import and manufacture generic HIV/AIDS drug treatments.

The agreement calls on the 53 member states of the Organization of African Unity to import and produce their own generic drugs, "preferably in partnership with donors and pharmaceutical companies," and for the governments of each member state to ratify the declaration through their legislative chambers, according to Associated Press reports.

The Summit was organized by the Nigerian government, the OAU and the World Health Organization.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight